PTPIP51 is phosphorylated by Lyn and c-Src kinases lacking dephosphorylation by PTP1B in acute myeloid leukemia

Leukemia Research

Volumn 35, Issue 10, 2011, Pages 1367-1375

  Brobeil, Alexander ^a   Bobrich, Manuel ^a   Graf, Michaela ^a   Kruchten, Anke ^a   Blau, Wolfgang ^a   Rummel, Mathias ^a   Oeschger, Sabine ^a   Steger, Klaus ^a   Wimmer, Monika ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute myeloid leukemia; C Kit; PTP1B; PTPIP51; SFK

Indexed keywords

MESSENGER RNA; PROTEIN KINASE LYN; PROTEIN KINASE P60; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE INTERACTING PROTEIN 51; RAF PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL INTERACTION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; LEUKEMIA CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TYROSINE PHOSPHATASE 1B GENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIBODIES; BONE MARROW; DNA PROBES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, ACUTE; MICROSCOPY, FLUORESCENCE; MITOCHONDRIAL PROTEINS; MYELOID PROGENITOR CELLS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYROSINE;

EID: 80052081463     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.03.024     Document Type: Article

References (32)

1. Deschler B., Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006, 107:2099-2107.
2. Shipley J.L., Butera J.N. Acute myelogenous leukemia. Exp Hematol 2009, 37:649-658.
3. Bacher U., Schnittger S., Haferlach C., Haferlach T. Molecular diagnostics in acute leukemias. Clin Chem Lab Med 2009, 47:1333-1341.
4. Mrózek K., Bloomfield C.D. Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2006, 169-177.
5. Stirewalt D.L., Meshinchi S., Radich J.P. Molecular targets in acute myelogenous leukemia. Blood Rev 2003, 17:15-23.
6. Brobeil A., Graf M., Oeschger S., Steger K., Wimmer M. PTPIP51-a myeloid lineage specific protein interacts with PTP1B in neutrophil granulocytes. Blood Cells Mol Dis 2010, 45:159-168.
7. Stenzinger A., Schreiner D., Koch P., Hofer H.W., Wimmer M. Cell and molecular biology of the novel protein tyrosine-phosphatase-interacting protein 51. Int Rev Cell Mol Biol 2009, 275:183-246.
8. Stenzinger A., Kajosch T., Tag C., Porsche A., Welte I., Hofer H.W., et al. The novel protein PTPIP51 exhibits tissue- and cell-specific expression. Histochem Cell Biol 2005, 123:19-28.
9. Maerker D., Stenzinger A., Schreiner D., Tag C., Wimmer M. Expression of PTPIP51 during mouse eye development. Histochem Cell Biol 2008, 129:345-356.
10. Robinson L.J., Xue J., Corey S.J. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations. Exp Hematol 2005, 33:469-479.
11. Dos Santos C., Demur C., Bardet V., Prade-Houdellier N., Payrastre B., Récher C. A critical role for Lyn in acute myeloid leukemia. Blood 2008, 111:2269-2279.
12. Schmidt-Arras D.E., Böhmer A., Markova B., Choudhary C., Serve H., Böhmer F.D. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Mol Cell Biol 2005, 25:3690-3703.
13. Choudhary C., Brandts C., Schwable J., Tickenbrock L., Sargin B., Ueker A., et al. Activation mechanisms of STAT5 by oncogenic Flt3-ITD. Blood 2007, 110:370-374.
14. Koch P., Viard M., Stenzinger A., Brobeil A., Tag C., Steger K., et al. Expression profile of PTPIP51 in mouse brain. J Comp Neurol 2009, 517:892-905.
15. Gajadhar A., Guha A. A proximity ligation assay using transiently transfected, epitope-tagged proteins: application for in situ detection of dimerized receptor tyrosine kinases. Biotechniques 2010, 48:145-152.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-428.
17. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354.
18. Gallagher R., Collins S., Trujillo J., McCredie K., Ahearn M., Tsai S., et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979, 54:713-733.
19. Malaise M., Steinbach D., Corbacioglu S. Clinical implications of c-Kit mutations in acute myelogenous leukemia. Curr Hematol Malig Rep 2009, 4:77-82.
20. Kitamura Y., Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 2004, 61:2924-2931.
21. Linnekin D., DeBerry C.S., Mou S. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. J Biol Chem 1997, 272:27450-27455.
22. Dubé N., Tremblay M.L. Beyond the metabolic function of PTP1B. Cell Cycle 2004, 3:550-553.
23. Heinonen K.M., Dubé N., Bourdeau A., Lapp W.S., Tremblay M.L. Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling. Proc Natl Acad Sci USA 2006, 103:2776-2781.
24. Roberts K.G., Smith A.M., McDougall F., Carpenter H., Horan M., Neviani P., et al. Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. Cancer Res 2010, 70:5438-5447.
25. Jin J., Smith F.D., Stark C., Wells C.D., Fawcett J.P., Kulkarni S., et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004, 14:1436-1450.
26. Yu C., Han W., Shi T., Lv B., He Q., Zhang Y., et al. PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway. Cell Signal 2008, 20:2208-2220.
27. Brobeil A., Bobrich M., Wimmer M. Protein tyrosine phosphatase interacting protein 51-a jack-of-all-trades protein. Cell Tissue Res 2011, (March). [Epub ahead of print]. 10.1007/s00441-011-1146-1.
28. Xue Y., Ren J., Gao X., Jin C., Wen L., Yao X. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol Cell Proteomics 2008, 7:1598-1608.
29. Lv B.F., Yu C.F., Chen Y.Y., Lu Y., Guo J.H., Song Q.S., et al. Protein tyrosine phosphatase interacting protein 51 (PTPIP51) is a novel mitochondria protein with an N-terminal mitochondrial targeting sequence and induces apoptosis. Apoptosis 2006, 11:1489-1501.
30. Doepfner K.T., Boller D., Arcaro A. Targeting receptor tyrosine kinase signaling in acute myeloid leukemia. Crit Rev Oncol Hematol 2007, 63:215-230.
31. Meshinchi S., Appelbaum F.R. Structural and functional alterations of FLT3 in acute myeloid leukemia. Clin Cancer Res 2009, 15:4263-4269.
32. Masson K., Rönnstrand L. Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signal 2009, 21:1717-1726.